Zelnorm (tegaserod), a new drug for irritable bowel syndrome
Novartis will soon market Zelnorm (tegaserod), a new drug for irritable bowel syndrome.
Zelnorm is the first in a new class...5-HT4 serotonin partial agonist. It STIMULATES bowel motility to reduce abdominal pain...bloating...and constipation. It's for CONSTIPATION-predominant IBS.
This is different from Lotronex, which is a 5-HT3 serotonin antagonist that SLOWS bowel motility...for DIARRHEA-predominant IBS.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote